Skip to main content

Induced Dopaminergic Neurons for Parkinson’s Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A 2010, 107: 15921–15926.

    CAS  Article  Google Scholar 

  2. Kang XJ, Xu HD, Teng SS, Zhang XY, Deng ZJ, Zhou L, et al. Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo. Proc Natl Acad Sci U S A 2014, 111: 15804–15809.

    CAS  Article  Google Scholar 

  3. Torper O, Pfisterer U, Wolf DA, Pereira M, Lau S, Jakobsson J, et al. Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci U S A 2013, 110: 7038–7043.

    CAS  Article  Google Scholar 

  4. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463: 1035–1041.

    CAS  Article  Google Scholar 

  5. Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ, et al. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476: 220–223.

    CAS  Article  Google Scholar 

  6. Kim J, Su SC, Wang HY, Cheng AW, Cassady JP, Lodato MA, et al. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell 2011, 9: 413–419.

    CAS  Article  Google Scholar 

  7. Liu XJ, Li F, Stubblefield EA, Blanchard B, Richards TL, Larson GA, et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res 2012, 22: 321–332.

    CAS  Article  Google Scholar 

  8. Dimou LD, Götz M. Glial cells as progenitors and stem cells: New roles in the healthy and diseased brain. Physiol Rev 2014, 94: 709–737.

    CAS  Article  Google Scholar 

  9. Karimi-Abdolrezaee S, Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol 2012, 46: 251–264.

    CAS  Article  Google Scholar 

  10. Wang LL, Serrano C, Zhong XL, Ma SP, Zou YH, Zhang CL. Revisiting astrocyte to neuron conversion with lineage tracing in vivo. Cell 2021, 184: 5465-5481.e16.

    CAS  Article  Google Scholar 

  11. Xiang ZQ, Xu L, Liu MH, Wang QS, Li W, Lei WL, et al. Lineage tracing of direct astrocyte-to-neuron conversion in the mouse cortex. Neural Regen Res 2021, 16: 750–756.

    Article  Google Scholar 

  12. Grande A, Sumiyoshi K, López-Juárez A, Howard J, Sakthivel B, Aronow B, et al. Environmental impact on direct neuronal reprogramming in vivo in the adult brain. Nat Commun 2013, 4: 2373.

    Article  Google Scholar 

  13. Niu WZ, Zang T, Smith DK, Vue TY, Zou YH, Bachoo R, et al. SOX2 reprograms resident astrocytes into neural progenitors in the adult brain. Stem Cell Reports 2015, 4: 780–794.

    CAS  Article  Google Scholar 

  14. Niu WZ, Zang T, Zou YH, Fang SH, Smith DK, Bachoo R, et al. In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat Cell Biol 2013, 15: 1164–1175.

    CAS  Article  Google Scholar 

  15. Pereira M, Birtele M, Shrigley S, Benitez JA, Hedlund E, Parmar M, et al. Direct reprogramming of resident NG2 Glia into neurons with properties of fast-spiking parvalbumin-containing interneurons. Stem Cell Reports 2017, 9: 742–751.

    CAS  Article  Google Scholar 

  16. Rivetti di Val Cervo P, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nat Biotechnol 2017, 35: 444–452.

  17. Torper O, Ottosson DR, Pereira M, Lau S, Cardoso T, Grealish S, et al. In vivo reprogramming of striatal NG2 Glia into functional neurons that integrate into local host circuitry. Cell Rep 2015, 12: 474–481.

    CAS  Article  Google Scholar 

  18. Weinberg MS, Criswell HE, Powell SK, Bhatt AP, McCown TJ. Viral vector reprogramming of adult resident striatal oligodendrocytes into functional neurons. Mol Ther 2017, 25: 928–934.

    CAS  Article  Google Scholar 

  19. Yoo J, Lee E, Kim HY, Youn DH, Jung J, Kim H, et al. Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson’s disease therapy. Nat Nanotechnol 2017, 12: 1006–1014.

    CAS  Article  Google Scholar 

  20. Zhou HB, Su JL, Hu XD, Zhou CY, Li H, Chen ZR, et al. Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice. Cell 2020, 181: 590-603.e16.

    CAS  Article  Google Scholar 

  21. Wang FC, Cheng LP, Zhang XH. Reprogramming glial cells into functional neurons for neuro-regeneration: Challenges and promise. Neurosci Bull 2021, 37: 1625–1636.

    Article  Google Scholar 

  22. Mattugini N, Bocchi R, Scheuss V, Russo GL, Torper O, Lao CL, et al. Inducing different neuronal subtypes from astrocytes in the injured mouse cerebral cortex. Neuron 2019, 103: 1086-1095.e5.

    CAS  Article  Google Scholar 

  23. Xiong M, Tao YZ, Gao QQ, Feng B, Yan W, Zhou YY, et al. Human stem cell-derived neurons repair circuits and restore neural function. Cell Stem Cell 2021, 28: 112-126.e6.

    CAS  Article  Google Scholar 

  24. Israel Z, Asch N. Reversing a model of Parkinson’s disease with in situ converted nigral neurons. Mov Disord 1955, 2020: 35.

    Google Scholar 

Download references

Acknowledgements

This insight was supported by the National Natural Science Foundation of China (32171233, 32000704, 81974203, 81901308, 31670843, 21790390, and 21790394), the Natural Science Foundation of Sichuan Province, China (2020YJ0337 and 2020YJ0378), the Natural Science Foundation of Shaanxi Province of China (2020JQ-029 and 2019JC-07), the Key Research and Development Program of Shaanxi Province, China (2017SF-113), the Science and Technology Innovation Projects of China (20-163-00-TS-009-035-01), China Postdoctoral Science Foundation (2018M640972), and the Innovation Capability Support Programof Shaanxi Province, China (2021TD-37).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Changhe Wang or Xinjiang Kang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xu, H., Cheng, X., Song, Q. et al. Induced Dopaminergic Neurons for Parkinson’s Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?. Neurosci. Bull. 38, 820–824 (2022). https://doi.org/10.1007/s12264-022-00829-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-022-00829-6